MedTrace Logo

Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research

NCT02351388 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-02-26

No results posted yet for this study

Summary

This project will investigate the safety and efficacy of transcranial direct current stimulation (tDCS) in the treatment of depression among patients with Alzheimer's disease. The investigators aim to ameliorate depressive symptoms among patient with Alzheimer's disease, by anodal stimulation on left dorsolateral prefrontal cortex and cathodal suppression on right supraorbital area. Active stimulation will be compare to sham condition in 20 patients (10 in each groups).

Conditions

Interventions

DEVICE

Transcranial Direct Current Stimulation

OTHER

Sham Stimulation

Sponsors & Collaborators

  • National Center of Neurology and Psychiatry, Japan

    lead OTHER

Principal Investigators

  • Yuma Yokoi, MD · National Center of Neurology and Psychiatry, Japan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-12-31
Completion
2018-03-15

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351388 on ClinicalTrials.gov